Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 45, 2015 - Issue 6
183
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Identification and functional characterization of novel feline cytochrome P450 2A

, , , , , , , , , , & show all
Pages 503-510 | Received 08 Nov 2014, Accepted 10 Dec 2014, Published online: 30 Dec 2014

References

  • Achour B, Barber J, Rostami-Hodjegan A. (2011). Cytochrome P450 Pig liver pie: determination of individual cytochrome P450 isoform contents in microsomes from two pig livers using liquid chromatography in conjunction with mass spectrometry. Drug Metab Dispos 39:2130–4
  • Bao Z, He XY, Ding X, et al. (2005). Metabolism of nicotine and cotinine by human cytochrome P450 2A13. Drug Metab Dispos 33:258–61
  • Barnes HJ. (1996). Maximizing expression of eukaryotic cytochrome P450s in Escherichia coli. Methods Enzymol 272:3–14
  • Bogaards JJ, Bertrand M, Jackson P, et al. (2000). Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica 30:1131–52
  • Chauret N, Gauthier A, Martin J, Nicoll-Griffith DA. (1997). In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse. Drug Metab Dispos 25:1130–6
  • Court MH, Greenblatt DJ. (2000). Molecular genetic basis for deficient acetaminophen glucuronidation by cats: UGT1A6 is a pseudogene, and evidence for reduced diversity of expressed hepatic UGT1A isoforms. Pharmacogenetics 10:355–69
  • Donato MT, Jiménez N, Castell JV, Gómez-Lechón MJ. (2004). Fluorescence-based assays for screening nine cytochrome P450 (P450) activities in intact cells expressing individual human P450 enzymes. Drug Metab Dispos 32:699–706
  • Guengerich FP. (1997). Comparisons of catalytic selectivity of cytochrome P450 subfamily enzymes from different species. Chem Biol Interact 106:161–82
  • Han S, Choi S, Chun YJ, et al. (2012). Functional characterization of allelic variants of polymorphic human cytochrome P450 2A6 (CYP2A6*5, *7, *8, *18, *19, and *35). Biol Pharm Bul 35:394–9
  • He XY, Tang L, Wang SL, et al. (2006). Efficient activation of aflatoxin B1 by cytochrome P450 2A13, an enzyme predominantly expressed in human respiratory tract. Int J Cancer 118:2665–71
  • Honda K, Komatsu T, Koyama F, et al. (2011). Expression of two novel cytochrome P450 3A131 and 3A132 in liver and small intestine of domestic cats. J Vet Med Sci 73:1489–92
  • Honkakoski P, Negishi M. (1997). The structure, function, and regulation of cytochrome P450 2A enzymes. Drug Metab Rev 29:977–96
  • Iwata H, Fujita K, Kushida H, et al. (1998). High catalytic activity of human cytochrome P450 co-expressed with human NADPH-cytochrome P450 reductase in Escherichia coli. Biochem Pharmacol 55:1315–25
  • Komatsu T, Honda K, Kubota A, et al. (2010). Molecular cloning and expression of cytochrome P450 2D6 in the livers of domestic cats. J Vet Med Sci 72:1633–6
  • Kubota A, Iwata H, Tanabe S, et al. (2005). Hepatic CYP1A induction by dioxin-like compounds, and congener-specific metabolism and sequestration in wild common cormorants from Lake Biwa, Japan. Environ Sci Technol 39:3611–19
  • Legrand-Defretin V. (1994). Differences between cats and dogs: a nutritional view. Proc Nutr Soc 53:15–24
  • Lindberg RL, Negishi M. (1989). Alteration of mouse cytochrome P450coh substrate specificity by mutation of a single amino-acid residue. Nature 339:632–34
  • Martignoni M, Groothuis GM, de Kanter R. (2006). Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol 2:875–94
  • Nelson DR. (2009). The cytochrome P450 homepage. Human Genomics 4:59–65
  • Omura T, Sato R. (1964). The carbon monoxide-binding pigment of liver microsomes. II. Solubilization, purification and properties. J Biol Chem 239:2379–85
  • Onaga T, Yoshida M, Inoue H, Yokota H. (2000). Regional distribution and plasma concentration of peptide YY in sheep. Peptides 21:655–67
  • Pearce R, Greenway D, Parkinson A. (1992). Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation. Arch Biochem Biophys 298:211–25
  • Pritchard MP, McLaughlin L, Friedberg T. (2006). Establishment of functional human cytochrome P450 monooxygenase systems in Escherichia coli. In: Phillips IR, Elizabeth AS, eds. Methods in molecular biology. New Jersey: Human Press, 19–29
  • Rabbaa-Khabbaz L, Daoud AR, Karam-Sarkis DA. (2006). Simple, sensitive, and rapid method for the determination of cotinine in urine by high-performance liquid chromatography with UV detection. J Chromatogr Sci 44:535–8
  • Shah SS, Sanda S, Regmi NL, et al. (2007). Characterization of cytochrome P450-mediated drug metabolism in cats. J Vet Pharmacol Ther 30:422–8
  • Skaanild MT, Friis C. (2005). Porcine CYP2A polymorphisms and activity. Basic Clin Pharmacol Toxicol 97:115–21
  • Tanaka N, Miyasho T, Shinkyo R, et al. (2006). cDNA cloning and characterization of feline CYP1A1 and CYP1A2. Life Sci 79:2463–73
  • Tanaka N, Shinkyo R, Sakaki T, et al. (2005). Cytochrome P450 2E polymorphism in feline liver. Biochim Biophys Acta 1726: 194–205
  • Tiong KH, Yiap BC, Tan EL, et al. (2010). Functional characterization of cytochrome P450 2A6 allelic variants CYP2A6*15, CYP2A6*16, CYP2A6*21, and CYP2A6*22. Drug Metab Dispos 38:745–51
  • Uehara S, Murayama N, Nakanishi Y, et al. (2011). Immunochemical detection of cytochrome P450 enzymes in liver microsomes of 27 cynomolgus monkeys. J Pharmacol Exp Ther 339:654–61
  • Uehara S, Murayama N, Yamazaki H, Uno Y. (2010). A novel CYP2A26 identified in cynomolgus monkey liver metabolizes coumarin. Xenobiotica 40:621–9
  • Uno T, Obe Y, Ogura C, et al. (2013). Metabolism of 7-ethoxycoumarin, safrole, flavanone and hydroxyflavanone by cytochrome P450 2A6 variants. Biopharm Drug Dispos 34:87–97
  • Uno Y, Fujino H, Kito G, et al. (2006). CYP2C76, a novel cytochrome P450 in cynomolgus monkey, is a major CYP2C in liver, metabolizing tolbutamide and testosterone. Mol Pharmacol 70:477–86
  • van Beusekom, CD, Schipper L, Fink-Gremmels J. (2010). Cytochrome P450-mediated hepatic metabolism of new fluorescent substrates in cats and dogs. J Vet Pharmacol Ther 233:519–27
  • von Weymarn LB, Retzlaff C, Murphy SE. (2006). Inactivation of CYP2A6 and CYP2A13 during nicotine metabolism. J Pharmacol Exp Ther 316:295–303
  • Waxman DJ, Chang TK. (2006). Spectrofluorometric analysis of CYP2A6-catalyzed coumarin 7-hydroxylation. Methods Mol Biol 320:91–6
  • Zhou D, Linnenbach AJ, Liu R, et al. (2010). Expression and characterization of dog cytochrome P450 2A13 and 2A25 in baculovirus-infected insect cells. Drug Metab Dispos 38:1015–18

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.